Boston Scientific has purchased the LumenR Tissue Retractor System from LumenR for an undisclosed amount.

The LumenR system has been designed to improve endoscopic sub-mucosal dissection (ESD) and endoscopic mucosal resection (EMR) procedures which are less invasive alternatives to conventional surgeries to remove precancerous lesions and malignant tumours in the gastrointestinal tract.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The system improves visualisation of lesions and fosters a stable working environment for tissue retraction and resection conducted during these procedures.

"By bringing this innovative technology forward, we have an opportunity for more physicians to treat patients successfully through less invasive endoscopic procedures."

ESD and EMR procedures are performed as part of endoscopic treatments for colorectal, gastric and esophageal cancers.

The treatment reduces the cost of inpatient stays and avoids adverse events associated with traditional surgery.

See Also:

Boston Scientific endoscopy senior vice-president and president Art Butcher said: "We are excited about the potential of the LumenR system to improve visibility and control during ESD and EMR procedures and improve quality of life for patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"Every year, patients around the world undergo open gastrointestinal surgery that has a profound impact on their lives.

"By bringing this innovative technology forward, we have an opportunity for more physicians to treat patients successfully through less invasive endoscopic procedures."

The LumenR system will be integrated into Boston Scientific’s endoscopy development programme and will undergo additional development and evaluation before the commercialisation of the system.